Akums Drugs and Pharmaceuticals Ltd - 544222 - General Update
General Update04-09-2024
Akums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Earnings / Analyst Conference Call held for limited reviewed un-audited financial results of Q1 FY25.04-09-2024
Akums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of Earnings/Analysts Conference Call held for limited reviewed un-audited financial results of Q1 FY25.30-08-2024
Akums Drugs and Pharmaceuticals back in black with 42 crore standalone net profit for June quarter
The company reported a revenue of 317 crore for the period under review. Revenues were near flat on a y-o-y basis at 316 crore27-08-2024
Akums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication26-08-2024
Akums Drugs and Pharmaceuticals Ltd - 544222 - Appointment Of Mr. Amrut Medhekar As Chief Executive Officer- CDMO Business
Appointment of Mr. Amrut Medhekar as Chief Executive Officer- CDMO Business24-08-2024
Akums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation24-08-2024
Akums Drugs and Pharmaceuticals Ltd - 544222 - Un-Audited Financial Results For The Quarter Ended 30.06.2024
Un-Audited Financial Results for the quarter ended 30.06.202424-08-2024